An SLE patient with persistent elevated conjugated bilirubin as the initial symptom: a case reportJun Liu1, Ying Huang1, Tingting Shen1, Xingyi Li2, Fang Zhao3, Xiaoxia Liu4, Shan Zhang4 ,Pengjia Wu4, Na Li4, Long Li4*, and Jiashun Zeng41Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China;ljsy013186vip.@qq.com.1Department of Rheumatology and Immunology, The 2nd Hospital Affiliated to Guizhou University of Chinese Traditional Medicine, Guiyang, Guizhou Province, China;40741698@qq.com.1Guizhou Provincial People’s Hospital, Guiyang, Guizhou Province, China;286165007@qq.com.2Guizhou Medical University, Guizhou Province, China.3045629556@qq.com.3Guizhou Medical University, Guizhou Province, China. ;626791899@qq.com.4Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; liuxiaoxiarain@163.com.4Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; shanzhang_ncu@qq.com.4Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; 1015066791@qq.com.4Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; 793875371@qq.com.4*Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; gzyxyll@medmail.com.cn.4Department of Rheumatology and Immunology, The Affiliated Hospital of Guizhou Medical University, Guiyang, Guizhou, China; zengjiashun@sina.com.Written informed consent was obtained from the patient to publish this report in accordance with the journal’s patient consent policy1.Data availability statement: All relevant data are within the paper.2.funding statement: This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.3.conflict of interest disclosure: All authors have no conflicts of interest. On behalf of all authors, the corresponding author states that there is no conflict of interest.4.ethics approval statement: The ethics committee approval from the authors’ institution have been obtained for this study.5.patient consent statement: Patients’ informed consent have been obtained for this study.6.permission to reproduce material from other sources: The study allows reproduction of the material from other sources.7.clinical trial registration：The study was retrospective and therefore not registered in clinical trials.